The TP53 pathway, involving the tumor suppressor p53, regulates crucial processes such as DNA repair and cell cycle arrest and is mutated in approximately 74% of CRC patients, significantly impacting genomic stability [16, 17, 18]. The gene discussed is TP53; the disease is colorectal carcinoma.